| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunocytochemistry; mouse; 1:300; fig 1
| Pandolfini L, Luzi E, Bressan D, Ucciferri N, Bertacchi M, Brandi R, et al. RISC-mediated control of selected chromatin regulators stabilizes ground state pluripotency of mouse embryonic stem cells. Genome Biol. 2016;17:94 pubmed publisher |
| Yao M, Su P, Li Z, Cui X, Yang Q, Xing X, et al. Knockout of Dip2c in murine ES cell line IBMSe001-B-1 by CRISPR/Cas9 genome editing technology. Stem Cell Res. 2021;53:102236 pubmed publisher |
| Li W, Kou J, Qin J, Li L, Zhang Z, Pan Y, et al. NADPH levels affect cellular epigenetic state by inhibiting HDAC3-Ncor complex. Nat Metab. 2021;3:75-89 pubmed publisher |
| Baruah J, Chaudhuri S, Mastej V, Axen C, Hitzman R, Ribeiro I, et al. Low-Level Nanog Expression in the Regulation of Quiescent Endothelium. Arterioscler Thromb Vasc Biol. 2020;40:2244-2264 pubmed publisher |
| Hayward B, Steinbach P, Usdin K. A point mutation in the nuclease domain of MLH3 eliminates repeat expansions in a mouse stem cell model of the Fragile X-related disorders. Nucleic Acids Res. 2020;: pubmed publisher |
| Sun H, Yang X, Liang L, Zhang M, Li Y, Chen J, et al. Metabolic switch and epithelial-mesenchymal transition cooperate to regulate pluripotency. EMBO J. 2020;39:e102961 pubmed publisher |
| Srivastava Y, Tan D, Malik V, Weng M, Javed A, Cojocaru V, et al. Cancer-associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17. FEBS J. 2020;287:122-144 pubmed publisher |
| Liu Z, Yao M, Yao H, Hu G, Qin B. Generation of Rybp homozygous knockout murine ES cell line GIBHe001-A-1 by using CRISPR/Cas9 technology. Stem Cell Res. 2019;41:101638 pubmed publisher |
| Malik V, Glaser L, Zimmer D, Velychko S, Weng M, Holzner M, et al. Pluripotency reprogramming by competent and incompetent POU factors uncovers temporal dependency for Oct4 and Sox2. Nat Commun. 2019;10:3477 pubmed publisher |
| Castelli A, Susani L, Menale C, Muggeo S, Caldana E, Strina D, et al. Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells. Stem Cells. 2019;37:876-887 pubmed publisher |
| Glennon E, Austin L, Arang N, Kain H, Mast F, Vijayan K, et al. Alterations in Phosphorylation of Hepatocyte Ribosomal Protein S6 Control Plasmodium Liver Stage Infection. Cell Rep. 2019;26:3391-3399.e4 pubmed publisher |
| Kodama Y, Harinath D, Mihara Tomiyama N, Tominaga N, Ide Y, Nakahara T, et al. Hmga2 regulation of tooth formation and association with Sox2 and Nanog expression. Biochem Biophys Res Commun. 2019;509:1008-1014 pubmed publisher |
| Ahmed M, El Sayed A, Chen H, Zhao R, Jin K, Zuo Q, et al. Direct conversion of mouse embryonic fibroblast to osteoblast cells using hLMP-3 with Yamanaka factors. Int J Biochem Cell Biol. 2019;106:84-95 pubmed publisher |
| Liu C, Cai Z, Jin G, Peng D, Pan B, Zhang X, et al. Abnormal gametogenesis induced by p53 deficiency promotes tumor progression and drug resistance. Cell Discov. 2018;4:54 pubmed publisher |
| Veerapandian V, Ackermann J, Srivastava Y, Malik V, Weng M, Yang X, et al. Directed Evolution of Reprogramming Factors by Cell Selection and Sequencing. Stem Cell Reports. 2018;11:593-606 pubmed publisher |
| Lee J, Kim M, Park S, Jang Y. Tousled-like kinase 1 is a negative regulator of core transcription factors in murine embryonic stem cells. Sci Rep. 2018;8:334 pubmed publisher |
| Zhang N, Lyu Y, Pan X, Xu L, Xuan A, He X, et al. miR‑146b‑5p promotes the neural conversion of pluripotent stem cells by targeting Smad4. Int J Mol Med. 2017;40:814-824 pubmed publisher |
| Ocampo A, Reddy P, Martínez Redondo P, Platero Luengo A, Hatanaka F, Hishida T, et al. In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. Cell. 2016;167:1719-1733.e12 pubmed publisher |
| Paulis M, Castelli A, Susani L, Lizier M, Lagutina I, Focarelli M, et al. Chromosome transplantation as a novel approach for correcting complex genomic disorders. Oncotarget. 2015;6:35218-30 pubmed publisher |
| Neri T, Muggeo S, Paulis M, Caldana M, Crisafulli L, Strina D, et al. Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts. Stem Cell Reports. 2015;5:558-68 pubmed publisher |
| Kim J, Liu Y, Qiu M, Xu Y. Pluripotency factor Nanog is tumorigenic by deregulating DNA damage response in somatic cells. Oncogene. 2016;35:1334-40 pubmed publisher |
| Palla A, Piazzolla D, Alcazar N, Cañamero M, Graña O, Gómez López G, et al. The pluripotency factor NANOG promotes the formation of squamous cell carcinomas. Sci Rep. 2015;5:10205 pubmed publisher |
| Kıykac Altınbaş S, Tapisiz O, Cavkaytar S, Sımşek G, Oguztuzun S, Goktolga U. Is montelukast effective in regression of endometrial implants in an experimentally induced endometriosis model in rats?. Eur J Obstet Gynecol Reprod Biol. 2015;184:7-12 pubmed publisher |
| Bertacchi M, Pandolfini L, D Onofrio M, Brandi R, Cremisi F. The double inhibition of endogenously produced BMP and Wnt factors synergistically triggers dorsal telencephalic differentiation of mouse ES cells. Dev Neurobiol. 2015;75:66-79 pubmed publisher |
| Piazzolla D, Palla A, Pantoja C, Canamero M, de Castro I, Ortega S, et al. Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia. Nat Commun. 2014;5:4226 pubmed publisher |
| Carelli S, Messaggio F, Canazza A, Hebda D, Caremoli F, Latorre E, et al. Characteristics and Properties of Mesenchymal Stem Cells Derived From Microfragmented Adipose Tissue. Cell Transplant. 2015;24:1233-52 pubmed publisher |
